Articles From: Pilgrim's Pride Corporation to Host 2014 First Quarter Earnings Call on May 1, 2014 to Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms


GREELEY, Colo., April 7, 2014 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (Nasdaq:PPC) announced today that it will host its first quarter 2014 earnings conference call and webcast on Thursday, May 1, 2014 at 7:00 a.m. MDT (9:00 a.m. EDT). Prepared remarks regarding the company's financial and operational results will be followed by a question and answer period with Pilgrim's executive management team.
Sign-up for Pilgrim's Pride Corporation to Host 2014 First Quarter Earnings Call on May 1, 2014 investment picks
CHARLOTTE, N.C., April 7, 2014 (GLOBE NEWSWIRE) -- Polypore International, Inc. (NYSE:PPO) will release its first quarter 2014 financial results after U.S. markets close on Thursday, May 8, 2014.
Sign-up for Polypore Sets First Quarter 2014 Earnings Release and Conference Call Date investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company") (Nasdaq:MDCO) and certain of its officers.
Sign-up for Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in The Medicines Company of Class Action Lawsuit and Upcoming Deadline -- MDCO investment picks
NORFOLK, Va., April 7, 2014 (GLOBE NEWSWIRE) -- Portfolio Recovery Associates, Inc. (Nasdaq:PRAA) , a financial and business services company operating in the U.S., Canada and the U.K., today announced it had modified its Credit Agreement of December 19, 2012, as amended, increasing the company's domestic revolving credit commitments by $214.5 million, successfully securing from existing and new lenders the maximum amount of the facility's accordion loan feature.
Sign-up for PRA Expands Credit Facility to $842.5 Million Moving Closer to Acquisition of Aktiv Kapital investment picks
CHARLOTTE, N.C., April 7, 2014 (GLOBE NEWSWIRE) -- Premier, Inc. (Nasdaq:PINC) today announced it has acquired MEMdata, LLC, an equipment planning, sourcing and analytics business focused on capital equipment needs for existing medical facilities, as well as those under construction.
Sign-up for Premier, Inc. Acquires MEMdata investment picks
REDWOOD CITY, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Qualys, Inc. (Nasdaq:QLYS) , a pioneer and leading provider of cloud security and compliance solutions, today announced that the company will report its financial results for the first quarter of 2014 after the market closes on Monday, May 5, 2014.
Sign-up for Qualys to Report First Quarter 2014 Financial Results on May 5th investment picks
WOODLAND HILLS, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- ReachLocal, Inc. (Nasdaq:RLOC) , a leader in powering local online marketing for small- to medium-sized businesses (SMBs), today announced it will report its first quarter 2014 financial results for the period ended March 31, 2014 following the close of market on Tuesday, May 6, 2014.
Sign-up for ReachLocal to Report First Quarter 2014 Results and Host Quarterly Conference Call on May 6 investment picks
The Company concluded a positive scientific advice meeting with the UK MHRA regarding RHB-102 and plans to submit, during the second half of the year, a European marketing application for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, oral pill formulation of the anti-emetic oncology support drug ondansetron The Company commenced a comparative bioavailability study with RHB-102 to support its planned European marketing application, with study results expected by July 2014 In addition to the currently pursued indications, the MHRA provided guidance regarding a new undisclosed indication which may significantly expand RHB-102's potential market; A Phase III study for this indication is planned in the U.S. for later this year TEL-AVIV, Israel, April 7, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 and Plans to Submit a European Marketing Application investment picks
COSTA MESA, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Pacific Mercantile Bancorp (Nasdaq:PMBC) and its wholly-owned subsidiary Pacific Mercantile Bank ("the Bank"), today announced that Robert J.
Sign-up for Robert J. Stevens Named EVP and Chief Credit Officer of Pacific Mercantile Bank investment picks
STEVENSON, Md., April 7, 2014 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Genworth Financial, Inc. ("Genworth" or the "Company") (NYSE:GNW) securities during the period between February 3, 2012 and April 17, 2012, inclusive (the "Class Period"). If you have suffered a loss from investment in Genworth securities purchased on or after February 3, 2012 and held through the revelation of negative information on April 17, 2012, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or financial obligation, click here: http://www.browerpiven.com/securitiesfraudcases.html .
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Genworth Financial, Inc. to Contact Brower Piven Before the June 3, 2014 Lead Plaintiff Deadline -- GNW investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Coty, Inc. ("Coty" or the "Company") (NYSE:COTY) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder With Losses on Their Investment in Coty, Inc. of Class Action Lawsuit and Upcoming Deadline -- COTY investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Montage Technology Group Ltd.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Montage Technology Group Ltd. of Class Action Lawsuit and Upcoming Deadline -- MONT investment picks
TAIPEI, Taiwan, April 7, 2014 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (Nasdaq:SIMO) ("Silicon Motion" or the "Company"), a global leader in designing and marketing NAND flash controllers for solid state storage devices and specialty RF IC solutions for mobile devices, announces that based upon its preliminary financial results, sequential revenue growth for the first quarter is expected to be near the high-end of the original guidance range that the company issued on January 28, 2014, of flat to down 10% sequentially.
Sign-up for Silicon Motion Announces Preliminary First Quarter 2014 Revenue and Earnings Conference Call Details investment picks
WHITE PLAINS, N.Y., April 7, 2014 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (Nasdaq:SGRP) ("we", the "Company" or "SPAR Group"), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced the appointment of Panos Mastrogiannis as Chief Information Officer and Executive Officer.
Sign-up for SPAR Group Appoints Chief Information Officer and Provides Shareholders With an Update on Its Technological Advances investment picks
COLORADO SPRINGS, Colo., April 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced preliminary results for the three months ended March 31, 2014.
Sign-up for Spectranetics Announces Preliminary Results for First Quarter 2014 and Updates 2014 Guidance investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 12:10 PM ET.
Sign-up for Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
GENEVA, April 7, 2014 (GLOBE NEWSWIRE) -- STMicroelectronics (NYSE:STM) , a global semiconductor leader serving customers across the spectrum of electronics applications, announced that it will release first quarter 2014 earnings after the close of trading on the New York Stock Exchange on Monday, April 28, 2014.
Sign-up for STMicroelectronics Announces Timing for 1st Quarter 2014 Earnings Release and Conference Call investment picks
SUGAR LAND, Texas, April 7, 2014 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) today announced financial results for its fiscal year 2014 third quarter ending February 28, 2014.
Sign-up for Team, Inc. Reports Third Quarter Results investment picks
CLEARWATER, Fla., April 7, 2014 (GLOBE NEWSWIRE) -- Tech Data Corporation (Nasdaq:TECD) today announced that it plans to host an investor conference call and webcast on April 9, 2014 at 9:00 a.m. ET to discuss results for its fourth quarter and fiscal year ended January 31, 2014.
Sign-up for Tech Data Corporation to Host Conference Call to Discuss Fourth-Quarter and Fiscal Year 2014 Results investment picks
SHAPE, a novel, tissue-targeted topical HDAC inhibitor, is expected to enter Phase 2 trials for early-stage CTCL Encouraging responses seen in a randomized Phase 1 trial after only 28 days of use, with no significant safety events SHAPE is designed to avoid systemic absorption and related HDACi toxicities Adds second clinical-stage oncology compound to the TetraLogic portfolio Conference call at 8:00 a.m., tomorrow, April 8, 2014 MALVERN, Pa., April 7, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) announced today that it has executed a definitive agreement to acquire by merger 100% of Shape Pharmaceuticals, a privately-held biotechnology company developing suberohydroxamic acid phenyl ester (SHAPE), a novel, tissue-targeted HDAC inhibitor in a topical gel formulation to treat stage IA-IIA Cutaneous T-Cell Lymphoma (CTCL), adding a second clinical-stage oncology compound to the TetraLogic portfolio.
Sign-up for TetraLogic Agrees to Acquire Shape Pharmaceuticals, Inc. investment picks
RIVERTON, Wyo., April 7, 2014 (GLOBE NEWSWIRE) -- U.S. Energy Corp.
Sign-up for U.S. Energy Corp. Provides Operational Update investment picks
NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- WisdomTree (Nasdaq:WETF) , an exchange-traded fund ("ETF") sponsor and asset manager, today announced the WisdomTree Europe Hedged Equity Fund (HEDJ) recently surpassed $1 billion in assets.
Sign-up for WisdomTree Europe Hedged Equity Fund (HEDJ) Surpasses $1 Billion in Assets investment picks
LEXINGTON, Mass., April 7, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:XBIO) , a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, today announced the positive results from its Phase I clinical trial of PulmoXen TM for the treatment of cystic fibrosis.
Sign-up for Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis investment picks
ROCKVILLE, Md., April 6, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX) , a clinical-stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced the presentation of pre-clinical data demonstrating that MGD007, a dual-affinity re-targeting (DART®) protein, has potent activity against colorectal cancer cells both in vitro and in vivo .
Sign-up for MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting investment picks
SALT LAKE CITY, April 4, 2014 (GLOBE NEWSWIRE) -- Amedica (Nasdaq:AMDA) announced today that it has been invited to present at the 13th Annual Needham Healthcare Conference, being held at the Westin Grand Central Hotel on April 8th and 9th in New York City.
Sign-up for Amedica to Present at the 13th Annual Needham Healthcare Conference investment picks
NEWARK, Del., April 4, 2014 (GLOBE NEWSWIRE) -- Artesian Resources Corporation (Nasdaq:ARTNA) announced today that its Board of Directors has approved a 1.5% increase in the company's Class A and Class B Common Stock dividend, raising the annual dividend to $0.8476 per share.
Sign-up for Artesian Resources Corporation Announces a 1.5% Increase in Common Stock Dividend investment picks
IRVINE, Calif., April 4, 2014 (GLOBE NEWSWIRE) -- The editors at Autobytel Inc. (Nasdaq:ABTL) , pioneer of the automotive Internet and the company dedicated to connecting automotive consumers with dealers, recently released truck shopping and buying highlights, and commentary regarding the road ahead for the popular pickup truck segment.
Sign-up for Autobytel Talks Trucks: Pickup Truck Shopping and Buying Highlights...and Trends for the Road Ahead investment picks
JERSEY CITY, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- BEL FUSE INC., (Nasdaq:BELFA) (Nasdaq:BELFB) will release financial results for the first quarter ended March 31, 2014 at approximately 7:30 a.m. EDT on Wednesday, April 30, 2014.
Sign-up for Bel to Release First Quarter Results on Wednesday, April 30, 2014; Conference Call & Webcast Set for 11:00 a.m. EDT investment picks
2014/4/4
MIAMI, April 4, 2014 (GLOBE NEWSWIRE) -- Big Data denotes the capture, curation, storage and analysis of high velocity complex data sets , often involving social media, demographics or purchasing history.
Sign-up for Big Data Powers E-Commerce investment picks
New Test Launch Extends CGI's Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI's Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for detecting mutations in the calreticulin (CALR) gene.
Sign-up for Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Pilgrim's Pride Corporation to Host 2014 First Quarter Earnings Call on May 1, 2014 to Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry